amikacin has been researched along with amphotericin b in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 9 (40.91) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaturvedi, AK; Shukla, PK; Singh, RV; Tandon, VK; Yadav, DB | 1 |
| Maurya, HK; Mishra, NN; Shukla, PK; Tandon, VK | 2 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Kumar, R; Maurya, HK; Shukla, PK; Tandon, VK; Verma, MK | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dwoskin, LP; Garneau-Tsodikova, S; Green, KD; Kril, LM; Kwiatkowski, S; Nickell, JR; Shrestha, SK; Sviripa, VM; Watt, DS | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
| Granatek, AP; Nunning, BC; Ricci, RA | 1 |
| Gary, LB; Hall, JW; Herndon, DN; Winkler, JB | 1 |
| de Jongh, CA; Joshi, JH; Newman, KA; Schimpff, SC; Tenney, JH | 1 |
| Bucaneve, G; Buelli, M; Carotenuto, M; D'Antonio, D; Gentile, G; Liso, V; Martino, P; Menichetti, F; Nosari, AM; Ricci, P | 1 |
| Klastersky, J | 1 |
| Aristimuño, B; Hemady, RK; Nirankari, VS; Rodrigues, MM | 1 |
| Benne, CA; Bruin, M; de Hoog, GS; Fleer, A; Neeleman, C | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Akova, YA; Arslan, H; Aydin, P; Bozbeyoglu, S; Haberal, M; Yilmaz, G | 1 |
| Al-Qasabi, SS; Nzeako, BC | 1 |
| Akan, H; Akan, O; Can, M; Demirtaş, S; Elmali, E | 1 |
| Goss, CH; Quon, BS; Ramsey, BW | 1 |
3 review(s) available for amikacin and amphotericin b
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Febrile neutropenia.
Topics: Amikacin; Amphotericin B; Bacteremia; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Mycoses; Neoplasms; Neutropenia; Vancomycin; Virus Diseases | 1993 |
Inhaled antibiotics for lower airway infections.
Topics: Administration, Inhalation; Amikacin; Amphotericin B; Anti-Bacterial Agents; Aztreonam; Ceftazidime; Colistin; Cystic Fibrosis; Gentamicins; Humans; Nebulizers and Vaporizers; Respiratory Tract Infections; Tobramycin | 2014 |
2 trial(s) available for amikacin and amphotericin b
| Article | Year |
|---|---|
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Topics: Adolescent; Adult; Aged; Amikacin; Amphotericin B; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Teicoplanin; Vancomycin | 1994 |
Cystatin C can be affected by nonrenal factors: a preliminary study on leukemia.
Topics: Acyclovir; Adult; Amikacin; Amphotericin B; Biomarkers; Bone Marrow Transplantation; Creatinine; Cyclosporine; Cystatin C; Cystatins; Female; Glomerular Filtration Rate; Humans; Leukemia; Male; Metabolic Clearance Rate | 2006 |
17 other study(ies) available for amikacin and amphotericin b
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
Topics: Amino Acids; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Methyl Ethers; Molecular Structure; Naphthoquinones | 2005 |
Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Drug Design; Fungi; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Green Chemistry Technology; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur; Water | 2010 |
Micelles catalyzed chemoselective synthesis 'in water' and biological evaluation of oxygen containing hetero-1,4-naphthoquinones as potential antifungal agents.
Topics: Antifungal Agents; Candida; Catalysis; Drug Evaluation, Preclinical; Micelles; Microbial Sensitivity Tests; Naphthoquinones; Oxygen; Sporothrix; Trichophyton; Water | 2011 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Bis(N-amidinohydrazones) and N-(amidino)-N'-aryl-bishydrazones: New classes of antibacterial/antifungal agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Candida albicans; Candidiasis; Cell Line; Drug Discovery; Drug Resistance, Multiple; Fungi; Humans; Hydrazones; Microbial Sensitivity Tests; Mycoses | 2017 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Physical compatibility and chemical stability of amikacin sulfate in combination with antibiotics in large-volume parenteral solutions - part III.
Topics: Amikacin; Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Drug Combinations; Drug Incompatibility; Drug Stability; Erythromycin; Injections, Intravenous; Kanamycin; Lincomycin; Novobiocin; Penicillins; Polymyxins; Solutions; Tetracyclines; Time Factors; Vancomycin | 1976 |
Auditory brainstem response in young burn-wound patients treated with ototoxic drugs.
Topics: Adolescent; Amikacin; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Audiometry, Evoked Response; Brain Stem; Burns; Child; Child, Preschool; Female; Gentamicins; Hearing Disorders; Humans; Infant; Male; Vancomycin | 1986 |
Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?
Topics: Agranulocytosis; Amikacin; Amphotericin B; Anti-Bacterial Agents; Fever; Humans; Lactams; Neoplasms | 1984 |
Spontaneous ulcerative keratitis in immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Amikacin; Amphotericin B; Candida albicans; Cefazolin; Ciprofloxacin; Corneal Ulcer; Female; Gentamicins; HIV Seropositivity; Humans; Miconazole; Pseudomonas aeruginosa; Staphylococcus aureus; Substance Abuse, Intravenous; Vancomycin; Visual Acuity | 1993 |
Disseminating infection with Scytalidium dimidiatum in a granulocytopenic child.
Topics: Adolescent; Amikacin; Amphotericin B; Ceftazidime; Drug Therapy, Combination; Humans; Immunocompromised Host; Lymphoma, B-Cell; Male; Mitosporic Fungi; Morocco; Mycoses; Netherlands; Neutropenia; Vancomycin | 1993 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
Choroidal abscess due to nocardial infection in a renal allograft recipient.
Topics: Abscess; Amikacin; Amphotericin B; Cefotaxime; Choroid Diseases; Drug Therapy, Combination; Eye Infections, Bacterial; Fluorescein Angiography; Humans; Kidney Transplantation; Male; Middle Aged; Nocardia asteroides; Nocardia Infections; Transplantation, Homologous; Trimethoprim, Sulfamethoxazole Drug Combination; Vitreous Body | 2004 |
Evaluation of the neutralising capacity of bactec medium for some antibiotics.
Topics: Amikacin; Amoxicillin; Amphotericin B; Anti-Bacterial Agents; Bacteria; Chloramphenicol; Culture Media; Gentamicins; Penicillins; Vancomycin | 2004 |